McDonald’s is test-marketing the McPlant in all of its about 240 restaurants in the Bay Area for a limited time to expand the number of restaurants offering the product to 600 restaurants nationwide.
The fast-food giant has also been testing the McPlant in overseas markets, including the UK, the Netherlands, Austria, Sweden, and Denmark.
The vegetarian patty was developed in partnership with Beyond Meat and is made from ingredients like peas, rice, and potatoes. It is cooked on the same grill as meat-based and egg products
The company said the McPlant, which comes with American cheese, tomato, lettuce, pickles, onions, mayonnaise, ketchup, and mustard on a sesame seed bun, was created to give customers more delicious options.
Customers may request that their McPlant sandwich be made without cheese and mayonnaise.


IMF Reaches Staff-Level Agreement With Egypt, Opening Path to $3.8 Billion in Funding
Oil Prices Climb in Asian Trade as Venezuela Sanctions and Middle East Tensions Fuel Risk Premium
Japan Signals Possible Yen Intervention as Currency Weakens Despite BOJ Rate Hike
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
RBA Signals Possible Interest Rate Hike in 2026 as Inflation Pressures Persist
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Global Markets Rise as Tech Stocks Lead, Yen Strengthens, and Commodities Hit Record Highs
Precious Metals Rally as Silver and Platinum Outperform on Rate Cut Bets
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
EU Approves €90 Billion Ukraine Aid as Frozen Russian Asset Plan Stalls
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
U.S. Stocks End Week Higher as Tech Rally Offsets Consumer Weakness
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 



